Flex Vascular
PrivateLast Round
Series C
Oct 29, 2025
Total Funding Raised
$51M
Company Overview
Flex Vascular operates in Healthcare & Life Sciences and is based in Plymouth, Minnesota. Its latest recorded funding round was a Series C round in October 2025.
Flex Vascular is a medical device company that develops and markets endovascular medical devices for the treatment of peripheral arterial disease and stenoses of arteriovenous fistulas and grafts.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Flex Vascular Comparables
Compare Flex Vascular with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cagent Vascular | 91% | |
| Cardio Flow, Inc. | 82% | |
| Stryker Corporation | 79% |
For institutional investors. Book with your work email.
Flex Vascular Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Oct 29, 2025 | ||||
| Convertible Debt | Feb 12, 2025 | ||||
| Convertible Debt | Jan 31, 2023 | ||||
| Convertible Debt | Nov 23, 2021 | ||||
| Series B | Aug 15, 2017 | ||||
Series A | Dec 1, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Flex Vascular Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RiverVest Venture Partners | Convertible Debt, Series B |
| Endeavour Vision | Convertible Debt, Series C, Series B |
| S3 Ventures | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2026
Bruce Fiedler appointed as Chief Financial Officer.
- Oct 29, 2025
$28M round completed.
For institutional investors. Book with your work email.
Flex Vascular Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Flex Vascular's valuation, stock price, and market status.
Is Flex Vascular a public or private company?
Flex Vascular is a private company.
What is the current stock price of Flex Vascular?
Flex Vascular is a private company, so its shares have no public market price. Caplight tracks Flex Vascular's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Flex Vascular worth (valuation)?
Valuation information for Flex Vascular is not publicly available.
Can I buy Flex Vascular stock?
Flex Vascular shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Flex Vascular's last funding round?
Flex Vascular's most recent funding round was Series C on October 29, 2025.
Who are the main investors in Flex Vascular?
Key investors in Flex Vascular include RiverVest Venture Partners, Endeavour Vision, S3 Ventures.
Will Flex Vascular IPO soon?
No public IPO plans have been announced for Flex Vascular.
How can I track Flex Vascular secondary market activity?
Caplight tracks bids, offers, and trades in Flex Vascular's shares on secondary markets.